Form 8.3 - MEDICLINIC INTERNATIONAL PLC Amendment

RNS Number : 2116Q
Barclays PLC
16 February 2023
 

FORM 8.3

Amendment to Sale







PUBLIC OPENING POSITION DISCLOSURE/DEALING DISCLOSURE BY

A PERSON WITH INTERESTS IN RELEVANT SECURITIES REPRESENTING 1% OR

MORE

Rule 8.3 of the Takeover Code (the "Code")

1.

KEY INFORMATION

(a)

Full name of discloser:


Barclays PLC.






(b)

Owner or controller of interest and short



positions disclosed, if different from 1(a):

(c)

Name of offeror/offeree in relation to whose

MEDICLINIC INTERNATIONAL PLC


relevant securities this form relates:

(d)

If an exempt fund manager connected with an



offeror/offeree, state this and specify identity of


offeror/offeree:



(e)

Date position held/dealing undertaken:

09 February 2023

(f)

In addition to the company in 1(c) above, is the discloser making

NO

 



disclosures in respect of any other party to the offer?




2.

POSITIONS OF THE PERSON MAKING THE DISCLOSURE

(a)

Interests and short positions in the relevant securities of the offeror or offeree

 

to which the disclosure relates following the dealing (if any)

 

Class of relevant security:

10p ordinary




Interests

Short Positions


Number

(%)

Number

(%)

(1)

Relevant securities owned






and/or controlled:

11,905,032

1.61%

4,615,895

0.63%








(2)

Cash-settled derivatives:








4,526,285

0.61%

9,555,113

1.30%








(3)

Stock-settled derivatives (including options)






and agreements to purchase/sell:

0

0.00%

0

0.00%















TOTAL:


16,431,317

2.23%

14,171,008

1.92%








(b)

Rights to subscribe for new securities (including directors and other executive

 

options)

 






Class of relevant security in relation to


which subscription right exists

Details, including nature of the rights


concerned and relevant percentages:

3.

DEALINGS (IF ANY) BY THE PERSON MAKING THE DISCLOSURE

(a)

Purchases and sales





Class of relevant

Purchase/sale


Number of


Price per unit


security




securities




10p ordinary

Purchase

5,925

4.9773 GBP

10p ordinary

Purchase

7,152

4.9777 GBP

10p ordinary

Purchase

18,108

4.9760 GBP

10p ordinary

Purchase

53,684

4.9769 GBP

10p ordinary

Purchase

205,212

4.9780 GBP

10p ordinary

Sale

7,152

4.9780 GBP

10p ordinary

Sale

15,935

4.9760 GBP

10p ordinary

Sale

31,989

4.9734 GBP

10p ordinary

Sale

414,771

4.9765 GBP









(b)

Cash-settled derivative transactions




Class of


Product


Nature of dealing


Number of

Price per

relevant


description




reference

unit

security






securities


10p ordinary

 SWAP

Long

209

106.2899 ZAR

10p ordinary

 SWAP

Long

672

106.3219 ZAR

10p ordinary

 CFD

Long

2,109

106.0132 ZAR

10p ordinary

 SWAP

Long

2,843

106.1800 ZAR

10p ordinary

 SWAP

Long

2,893

106.3793 ZAR

10p ordinary

 SWAP

Long

3,042

4.9760 GBP

10p ordinary

 CFD

Long

10,264

4.9755 GBP

10p ordinary

 SWAP

Long

19,722

106.4000 ZAR

10p ordinary

 SWAP

Long

25,395

106.3974 ZAR

10p ordinary

 SWAP

Long

31,838

4.9732 GBP

10p ordinary

 SWAP

Long

414,771

4.9765 GBP

10p ordinary

 SWAP

Short

209

106.2899 ZAR

10p ordinary

 CFD

Short

571

4.9764 GBP

10p ordinary

 CFD

Short

672

106.3512 ZAR

10p ordinary

 SWAP

Short

2,100

4.9773 GBP

10p ordinary

 SWAP

Short

2,109

106.0450 ZAR

10p ordinary

 SWAP

Short

2,843

106.1800 ZAR

10p ordinary

 SWAP

Short

2,893

106.3793 ZAR

10p ordinary

 SWAP

Short

6,344

4.9775 GBP

10p ordinary

 SWAP

Short

19,722

106.4000 ZAR

10p ordinary

 SWAP

Short

21,672

4.9764 GBP

10p ordinary

 SWAP

Short

25,136

4.9778 GBP

10p ordinary

 CFD

Short

25,395

106.4267 ZAR

10p ordinary

 SWAP

Short

29,877

4.9763 GBP

10p ordinary

 SWAP

Short

194,449

4.9780 GBP









(c)

Stock-settled derivative transactions (including options)

 


(i)

Writing, selling, purchasing or varying

 



Class

Product

Writing,

Number

Exercise

Type

Expiry

Option

of

description

purchasing,

of

price


date

money

relevant


selling,

securities

per unit



paid/

security


varying etc

to which




received




option




per unit




relates





















(ii)

Exercising

 





Class of relevant

Product description

Exercising/ exercised against

Number of

Exercise price per

security




securities

unit














(d)

Other dealings (including subscribing for new securities)

 


Class of relevant

Nature of Dealings


Details

Price per unit (if


security




applicable)






4.

OTHER INFORMATION

(a)

Indemnity and other dealings arrangements

 



Details of any indemnity or option arrangement, or any agreement or understanding,

formal or informal, relating to relevant securities which may be an inducement to deal

or refrain from dealing entered into by the person making the disclosure and any party

to the offer or any person acting in concert with a party to the offer:


NONE

(b)

Agreements, arrangements or understandings relating to options or derivatives

Details of any agreement, arrangement or understanding, formal or informal, between

the person making the disclosure and any other person relating to:

 


(i)  the voting rights of any relevant securities under any option; or

 


(ii)  the voting rights of future acquisition or disposal of any relevant securities to which

any derivative is referenced:





NONE

(c)

Attachments

 





Is a Supplemental Form 8 (Open Positions) attached?

NO

Date of disclosure:

15 Feb 2023




Contact name:

Large Holdings Regulatory Operations

Telephone number:

020 3134 7213



 

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
RETUNVBROOUUAAR

Companies

Barclays (BARC)
UK 100

Latest directors dealings